BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 21720932)

  • 41. Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study.
    de Jong LW; van der Hiele K; Veer IM; Houwing JJ; Westendorp RG; Bollen EL; de Bruin PW; Middelkoop HA; van Buchem MA; van der Grond J
    Brain; 2008 Dec; 131(Pt 12):3277-85. PubMed ID: 19022861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
    Brochet B; Deloire MS; Bonnet M; Salort-Campana E; Ouallet JC; Petry KG; Dousset V
    Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased mean R2* in the deep gray matter of multiple sclerosis patients: Have we been measuring atrophy?
    Hernández-Torres E; Wiggermann V; Machan L; Sadovnick AD; Li DKB; Traboulsee A; Hametner S; Rauscher A
    J Magn Reson Imaging; 2019 Jul; 50(1):201-208. PubMed ID: 30511803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.
    Lazeron RH; Boringa JB; Schouten M; Uitdehaag BM; Bergers E; Lindeboom J; Eikelenboom MI; Scheltens PH; Barkhof F; Polman CH
    Mult Scler; 2005 Oct; 11(5):524-31. PubMed ID: 16193889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gray matter atrophy is associated with functional connectivity reorganization during the Paced Auditory Serial Addition Test (PASAT) execution in Multiple Sclerosis (MS).
    Baltruschat SA; Ventura-Campos N; Cruz-Gómez ÁJ; Belenguer A; Forn C
    J Neuroradiol; 2015 Jun; 42(3):141-9. PubMed ID: 25857687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI.
    Schweser F; Hagemeier J; Dwyer MG; Bergsland N; Hametner S; Weinstock-Guttman B; Zivadinov R
    Hum Brain Mapp; 2021 Apr; 42(5):1463-1474. PubMed ID: 33378095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.
    Jakimovski D; Weinstock-Guttman B; Hagemeier J; Vaughn CB; Kavak KS; Gandhi S; Bennett SE; Fuchs TA; Bergsland N; Dwyer MG; Benedict RHB; Zivadinov R
    J Neurol Sci; 2018 Oct; 393():128-134. PubMed ID: 30165291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Basal ganglia pathology in ALS is associated with neuropsychological deficits.
    Machts J; Loewe K; Kaufmann J; Jakubiczka S; Abdulla S; Petri S; Dengler R; Heinze HJ; Vielhaber S; Schoenfeld MA; Bede P
    Neurology; 2015 Oct; 85(15):1301-9. PubMed ID: 26385880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.
    Aylward EH; Harrington DL; Mills JA; Nopoulos PC; Ross CA; Long JD; Liu D; Westervelt HK; Paulsen JS;
    J Huntingtons Dis; 2013; 2(4):477-89. PubMed ID: 25062732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis.
    Bermel RA; Bakshi R; Tjoa C; Puli SR; Jacobs L
    Arch Neurol; 2002 Feb; 59(2):275-80. PubMed ID: 11843699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional hippocampal atrophy in multiple sclerosis.
    Sicotte NL; Kern KC; Giesser BS; Arshanapalli A; Schultz A; Montag M; Wang H; Bookheimer SY
    Brain; 2008 Apr; 131(Pt 4):1134-41. PubMed ID: 18375977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
    Uddin MN; Lebel RM; Seres P; Blevins G; Wilman AH
    Mult Scler; 2016 Aug; 22(9):1133-43. PubMed ID: 26503237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment.
    Grau-Olivares M; Bartrés-Faz D; Arboix A; Soliva JC; Rovira M; Targa C; Junqué C
    Cerebrovasc Dis; 2007; 23(5-6):353-61. PubMed ID: 17268166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
    Sonder JM; Burggraaff J; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2014 Apr; 20(4):481-8. PubMed ID: 24019305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease.
    Jurgens CK; van de Wiel L; van Es AC; Grimbergen YM; Witjes-Ané MN; van der Grond J; Middelkoop HA; Roos RA
    J Neurol; 2008 Nov; 255(11):1785-91. PubMed ID: 19156490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
    Patti F; De Stefano M; Lavorgna L; Messina S; Chisari CG; Ippolito D; Lanzillo R; Vacchiano V; Realmuto S; Valentino P; Coniglio G; Buccafusca M; Paolicelli D; D'Ambrosio A; Montella P; Brescia Morra V; Savettieri G; Alfano B; Gallo A; Simone I; Viterbo R; Zappia M; Bonavita S; Tedeschi G
    PLoS One; 2015; 10(3):e0120754. PubMed ID: 25816303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis.
    Benedict RH; Bruce J; Dwyer MG; Weinstock-Guttman B; Tjoa C; Tavazzi E; Munschauer FE; Zivadinov R
    Mult Scler; 2007 Jul; 13(6):722-30. PubMed ID: 17613599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.